A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

733

Participants

Timeline

Start Date

July 11, 2016

Primary Completion Date

May 17, 2019

Study Completion Date

January 30, 2026

Conditions
Ovarian Neoplasms
Interventions
DRUG

Niraparib

Niraparib will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (200)

8

GSK Investigational Site, Dublin

1000

GSK Investigational Site, Brussels

1200

GSK Investigational Site, Brussels

2100

GSK Investigational Site, Copenhagen

2730

GSK Investigational Site, Herlev

2820

GSK Investigational Site, Bonheiden

3000

GSK Investigational Site, Leuven

3010

GSK Investigational Site, Bern

3500

GSK Investigational Site, Hasselt

4031

GSK Investigational Site, Basel

4032

GSK Investigational Site, Debrecen

5000

GSK Investigational Site, Namur

GSK Investigational Site, Odense C

6000

GSK Investigational Site, Charleroi

6800

GSK Investigational Site, Libramont

8035

GSK Investigational Site, Barcelona

8091

GSK Investigational Site, Zurich

8501

GSK Investigational Site, Frauenfeld

9000

GSK Investigational Site, Ghent

GSK Investigational Site, Aalborg

9024

GSK Investigational Site, Győr

9100

GSK Investigational Site, Sint-Niklaas

10016

GSK Investigational Site, New York

10034

GSK Investigational Site, Prague

10060

GSK Investigational Site, Candiolo

10065

GSK Investigational Site, New York

10604

GSK Investigational Site, Harrison

11501

GSK Investigational Site, Mineola

13353

GSK Investigational Site, Berlin

14004

GSK Investigational Site, Córdoba

14076

GSK Investigational Site, Caen

14263

GSK Investigational Site, Buffalo

14620

GSK Investigational Site, Rochester

17007

GSK Investigational Site, Girona

19090

GSK Investigational Site, Willow Grove

19104

GSK Investigational Site, Philadelphia

20014

GSK Investigational Site, Donostia / San Sebastian

20132

GSK Investigational Site, Milan

20133

GSK Investigational Site, Milan

20246

GSK Investigational Site, Hamburg

20520

GSK Investigational Site, Turku

20910

GSK Investigational Site, Rockville

21029

GSK Investigational Site, Vinnytsia

26505

GSK Investigational Site, Morgantown

28033

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28401

GSK Investigational Site, Wilmington

29425

GSK Investigational Site, Charleston

30035

GSK Investigational Site, Mirano VE

30342

GSK Investigational Site, Atlanta

30460

GSK Investigational Site, Pilsen

30912

GSK Investigational Site, Augusta

31134

GSK Investigational Site, Hildesheim

31404

GSK Investigational Site, Savannah

32224

GSK Investigational Site, Jacksonville

33136

GSK Investigational Site, Miami

33323

GSK Investigational Site, Hollywood

33521

GSK Investigational Site, Tampere

34298

GSK Investigational Site, Montpellier

35042

GSK Investigational Site, Rennes

37075

GSK Investigational Site, Göttingen

38100

GSK Investigational Site, Haifa

41013

GSK Investigational Site, Seville

41014

GSK Investigational Site, Seville

41100

GSK Investigational Site, Modena

43210

GSK Investigational Site, Columbus

44111

GSK Investigational Site, Cleveland

44124

GSK Investigational Site, Cleveland

GSK Investigational Site, Mayfield Hts

44805

GSK Investigational Site, Saint-Herblain

45136

GSK Investigational Site, Essen

46009

GSK Investigational Site, Valencia

46010

GSK Investigational Site, Valencia

46237

GSK Investigational Site, Indianapolis

46260

GSK Investigational Site, Indianapolis

49000

GSK Investigational Site, Angers

49100

GSK Investigational Site, Petah Tikva

GSK Investigational Site, Dnipropetrovsk

49102

GSK Investigational Site, Dnipropetrovsk

49503

GSK Investigational Site, Grand Rapids

50009

GSK Investigational Site, Zaragoza

50048

GSK Investigational Site, Kryvyi Rih

52074

GSK Investigational Site, Aachen

52242

GSK Investigational Site, Iowa City

52621

GSK Investigational Site, Ramat Gan

53226

GSK Investigational Site, Milwaukee

55433

GSK Investigational Site, Minneapolis

57105

GSK Investigational Site, Sioux Falls

58100

GSK Investigational Site, Holon

60521

GSK Investigational Site, Hinsdale

60555

GSK Investigational Site, Geneva

GSK Investigational Site, Warrenville

60612

GSK Investigational Site, Chicago

61070

GSK Investigational Site, Kharkiv

64239

GSK Investigational Site, Tel Aviv

65807

GSK Investigational Site, Springfield

68167

GSK Investigational Site, Mannheim

69040

GSK Investigational Site, Zaporizhzhia

69120

GSK Investigational Site, Heidelberg

69495

GSK Investigational Site, Pierre-Bénite

70121

GSK Investigational Site, New Orleans

70210

GSK Investigational Site, Kuopio

70433

GSK Investigational Site, Covington

70817

GSK Investigational Site, Baton Rouge

73000

GSK Investigational Site, Kherson

73100

GSK Investigational Site, Lecce

73104

GSK Investigational Site, Oklahoma City

74146

GSK Investigational Site, Tulsa

75020

GSK Investigational Site, Paris

75701

GSK Investigational Site, Tyler

75908

GSK Investigational Site, Paris

76000

GSK Investigational Site, Ivano-Frankivsk

76104

GSK Investigational Site, Fort Worth

77380

GSK Investigational Site, The Woodlands

78229

GSK Investigational Site, San Antonio

78731

GSK Investigational Site, Austin

80131

GSK Investigational Site, Napoli

81377

GSK Investigational Site, München

81737

GSK Investigational Site, München

84101

GSK Investigational Site, Beersheba

84112

GSK Investigational Site, Salt Lake City

85284

GSK Investigational Site, Tempe

85710

GSK Investigational Site, Tucson

85724

GSK Investigational Site, Tucson

90029

GSK Investigational Site, Oulu

90095

GSK Investigational Site, Los Angeles

90766

GSK Investigational Site, Fürth

94115

GSK Investigational Site, San Francisco

94118

GSK Investigational Site, San Francisco

95403

GSK Investigational Site, Santa Rosa

97210

GSK Investigational Site, Portland

97477

GSK Investigational Site, Springfield

98104

GSK Investigational Site, Seattle

99202

GSK Investigational Site, Spokane

99336

GSK Investigational Site, Kennewick

153040

GSK Investigational Site, Ivanovo

163045

GSK Investigational Site, Arkhangelsk

191104

GSK Investigational Site, Saint Petersburg

194017

GSK Investigational Site, Saint Petersburg

197758

GSK Investigational Site, Saint Petersburg

357502

GSK Investigational Site, Pyatigorsk

420029

GSK Investigational Site, Kazan'

443011

GSK Investigational Site, Samara

454048

GSK Investigational Site, Chelyabinsk

460021

GSK Investigational Site, Orenburg

660133

GSK Investigational Site, Krasnoyarsk

664035

GSK Investigational Site, Irkutsk

3109601

GSK Investigational Site, Haifa

06102

GSK Investigational Site, Hartford

06510

GSK Investigational Site, New Haven

21215-5271

GSK Investigational Site, Baltimore

01805

GSK Investigational Site, Burlington

01199

GSK Investigational Site, Springfield

07748

GSK Investigational Site, Middletown

07753

GSK Investigational Site, Neptune City

07666

GSK Investigational Site, Teaneck

27599-7570

GSK Investigational Site, Chapel Hill

02905

GSK Investigational Site, Providence

T2N 4N2

GSK Investigational Site, Calgary

V1Y 5L3

GSK Investigational Site, Kelowna

V3V 1Z2

GSK Investigational Site, Surrey

V5Z 4E6

GSK Investigational Site, Vancouver

L4M 6M2

GSK Investigational Site, Barrie

N6A 4L6

GSK Investigational Site, London

K1Y 4E9

GSK Investigational Site, Ottawa

M4N 3M5

GSK Investigational Site, Toronto

M5G 1X6

GSK Investigational Site, Toronto

H2X 0A9

GSK Investigational Site, Montreal

H3T 1E2

GSK Investigational Site, Montreal

H4A 3J1

GSK Investigational Site, Montreal

708 52

GSK Investigational Site, Ostrava

128 51

GSK Investigational Site, Prague

06189

GSK Investigational Site, Nice

01307

GSK Investigational Site, Dresden

Unknown

GSK Investigational Site, Dunmore RoadWaterford

H91 YR71

GSK Investigational Site, Galway

0310

GSK Investigational Site, Oslo

20-090

GSK Investigational Site, Lublin

10-561

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

08916

GSK Investigational Site, Badalona

08003

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, Barcelona

03203

GSK Investigational Site, Elche Alicante

SE-171 76

GSK Investigational Site, Stockholm

SE-751 85

GSK Investigational Site, Uppsala

03022

GSK Investigational Site, Kyiv

BA1 3NG

GSK Investigational Site, Bath

BB2 3HH

GSK Investigational Site, Blackburn

G12 0YN

GSK Investigational Site, Edinburgh

GSK Investigational Site, Glasgow

EX2 5DW

GSK Investigational Site, Exeter

W12 0HS

GSK Investigational Site, London

PO6 3LY

GSK Investigational Site, Portsmouth

S10 2SJ

GSK Investigational Site, Sheffield

ST4 6QG

GSK Investigational Site, Staffordshire

TR1 3LJ

GSK Investigational Site, Truro

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

collaborator

European Network of Gynaecological Oncological Trial Groups (ENGOT)

OTHER

collaborator

Myriad Genetics, Inc.

INDUSTRY

lead

Tesaro, Inc.

INDUSTRY

NCT02655016 - A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy | Biotech Hunter | Biotech Hunter